Manuscripts

Search by keyword, year, or author name.

Showing 1587 manuscripts.

Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania

Habib O. Ramadhani, Nathan Thielman, Keren Z. Landman, Evaline M. Ndosi, Feng Gao, Jennifer L. Kirchherr, Rekha Shah, Humphrey J. Shao, Susan C. Morpeth, Jonathan D. McNeill, John F. Shao, John Alexander Bartlett, John A. Crump. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clinical Infectious Diseases. 2007. 45: 1492-8.

Year

2007

Journal

Clinical Infectious Diseases

Antiretroviral therapy for HIV-1-infected children in Haiti

Erik George, Francine Noel, Rose May Gyrlande Bois, Rachelle Cassagnol, Louise Estavien, Patricia De Matteis Rouzier, Rose I. Verdier, Warren D. Johnson, Jean William Pape, Daniel W. Fitzgerald, Peter Farnum Wright. Antiretroviral therapy for HIV-1-infected children in Haiti. Journal of Infectious Diseases. 2007. 195: 1411-8.

Year

2007

Journal

Journal of Infectious Diseases

Human b-defensin-3 activates professional antigen-presenting cells via toll-like receptors 1 and 2

Nicholas T. Funderburg, Michael M. Lederman, Zhimin Feng, Michael G. Drage, Julie Jadlowsky, Clifford V. Harding, Scott F. Sieg. Human b-defensin-3 activates professional antigen-presenting cells via toll-like receptors 1 and 2. Proceedings of the National Academy of Sciences of the United States of America. 2007. 104: 18631-5.

Year

2007

Journal

Proceedings of the National Academy of Sciences of the United States of America

Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration

Edward R. Cachay, Niousha Moini, Sergei L. Kosakovsky Pond, Rick L. Pesano, Yolanda Lie, Heidi Aiem, David M. Butler, Scott L. Letendre, W. Christopher Mathews, Davey M. Smith. Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration. The Open AIDS Journal. 2007. 1: 5-10.

Year

2007

Journal

The Open AIDS Journal

Antiretroviral drug levels and interactions affect lipid, lipoprotein and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic-pharmacodynamic analysis

Susan L Rosenkranz, Kevin E. Yarasheski, Michael F. Para, Richard C. Reichman, Gene D. Morse. Antiretroviral drug levels and interactions affect lipid, lipoprotein and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic-pharmacodynamic analysis. Metabolic Syndrome and Related Disorders. 2007. 5: 163-73.

Year

2007

Journal

Metabolic Syndrome and Related Disorders

Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants.

Carmen D. Zorrilla, Russell B. Van Dyke, Arlene D. Bardeguez, Edward P. Acosta, Elizabeth (Betsy) Smith, Michael Hughes, Sharon Huang, Heather D. Watts, Barbara E. Heckman, Barbara E. Heckman, Eleanor Jimenez, George D. McSherry, Lynne M. Mofenson. Clinical response and tolerability to and safety of saquinavir with low-dose ritonavir in human immunodeficiency virus type 1-infected mothers and their infants.. Antimicrobial Agents and Chemotherapy. 2007. 51: 2208 - 2210. PMID: 17420209

Year

2007

Journal

Antimicrobial Agents and Chemotherapy

Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels. Results of a prospective randomized trial (AIDS clinical trial group 5125s)

Pablo Tebas, Jiameng Zhang, Kevin E. Yarasheski, Scott Evans, Margaret A. Fischl, Abby Helen Shevitz, Judith Feinberg, Ann C. Collier, Cecilia M. Shikuma, Barbara Brizz, Fred Richard Sattler. Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels. Results of a prospective randomized trial (AIDS clinical trial group 5125s). Journal of Acquired Immune Deficiency Syndromes. 2007. 45: 193-200.

Year

2007

Journal

Journal of Acquired Immune Deficiency Syndromes